Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Aleksey Yefremov
Period: Reporting periods mapped to calendar 2024 Q4 – 2025 Q4 (5 quarters).
- Questions
- 29on tracked calls
- Challenge rate
- 7%2 of 29 questions
- Companies
- 8questioned at least once
- Reporting periods
- 5with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 29 of 29 questions from 8 companies
ALBAlbemarle Corporation7 questions · 4 reporting periods · 0 of 7 challenging
Calendar 2025 Q3
You mentioned you'll have better profitability because of higher spodumene prices. But how do you think this would evolve in maybe first half of '26?
Show response
Sheorey explained the dual dynamic: immediate equity earnings benefit from JV partner sales, but Albemarle's own spodumene costs lag 6-9 months. Net impact depends on salt prices 6 months out.
Calendar 2025 Q2
Did you pull those opportunities forward? Or could you bring CapEx down even more after -- after you just stepped it down?
Show response
Masters said they're very focused on further CapEx reduction but acknowledged it's getting harder to cut in large chunks.
Should we just think about this as the basis sort of, of the run rate for next year?
Show response
Masters cautioned against extrapolating H2 mix as a 2026 run rate, saying the ~50% LTA mix will persist and a couple of contracts up for renewal are expected to be extended.
Calendar 2025 Q1
You're forecasting demand to grow 200 to 600 kilotons this year. How much do you think the upstream capacity would be added this year as well?
Show response
Masters acknowledged some capacity additions but couldn't quantify exactly, saying the supply-demand balance stays roughly the same.
could you also broadly talk about your outlook for mining costs at both Wodgina and Greenbushes and maybe La Negra
Show response
Masters provided a site-by-site cost outlook: Greenbushes working through difficult mine area but CGP3 will add scale; La Negra is among the lowest-cost globally with Salar yield project ramping.
Calendar 2024 Q4
Any comments on risk assessment for delays, cost overruns, that kind of thing? Like how is the project going from your point of view?
Show response
Masters confirmed CGP3 is on schedule and approximately on budget.
Assuming market prices don't change, can you get to that maintenance level in 2026?
Show response
Masters declined to commit to 2026 CapEx levels but said the aspiration is to reach maintenance-level spending.
DDDuPont5 questions · 3 reporting periods · 1 of 5 challenging
Calendar 2025 Q4
Can you discuss what you're currently seeing in auto trends right now and maybe the cadence for your outlook for 2026
Show response
Koch noted IHS expects flat auto builds, with DuPont slightly outperforming on EV content growth. Nice EV growth in both 2025 and 2026 expected.
Calendar 2025 Q1
your full year sales guide is for 3% to 4% growth, that's acceleration from flat in 1Q. So what would get better here
Show response
Koch clarified the confusion between reported (flat) and organic (2% up), noting similar profile into Q2 with full-year trending toward lower end of 3-4%.
Is that still on the table sometime later in '25, or how do you think about that dynamic, as China being so strong last year?
Show response
Kemp reiterated flat China Semi for full year but noted customers report strong local demand without elevated inventories, suggesting risk may be to the upside.
Calendar 2024 Q4
Any further divestments or do you see any interesting bolt-ons here?
Show response
Koch confirmed active M&A pipeline focused on healthcare and Water, with willingness to look beyond filtration into broader Water landscape.
Do you have an assumption for underlying market growth in Semis and Interconnect
Show response
Koch provided specific MSI growth estimate (~6%), fab utilization (high 70s), and PCB/smartphone outlook (mid-single digits).
SHWThe Sherwin-Williams Company5 questions · 5 reporting periods · 0 of 5 challenging
Calendar 2025 Q4
I wanted to come back to your comments on focusing more on volumes than price this year.
Show response
Heidi reframed as 'balanced' not volume-over-price; emphasized trading contractors up to premium tiers where labor is 85-87% of their total cost.
Calendar 2025 Q3
I wanted to ask you about your comments on the second half of next year.
Show response
Heidi characterized outlook as pragmatic, not conservative; based on current sight line to backlogs and pipeline with no catalyst data points.
Calendar 2025 Q2
Do you expect to stay at roughly these levels of sales when we send them to the second half, or could there be more pronounced deterioration
Show response
Al characterized new res as bouncing along, already pressured; H2 Paint Stores volume down low single digits offset by higher price.
Calendar 2025 Q1
I wanted to come back to the consumer question was in PSG. I mean, your res repaints performance has been very solid and steady. But are you hearing like how are consumers reacting to current uncer...
Show response
Heidi said market is flat with consumers still willing to do affordable projects like painting; SHW's data and controlled model enable surgical engagement; launched Gallery Series cabinet/trim factory finish system to expand contractor wallet share.
Calendar 2024 Q4
what kind of demand improvement can your current footprint of stores and associates accommodate before you need to ramp up as G&A investments?
Show response
Heidi said current store footprint has the capacity to absorb growth while continuing 80-100 new stores/year; Al added reps are variable cost with 1-2 quarter lead time on volume improvement.
QQnity Electronics, Inc.4 questions · 2 reporting periods · 0 of 4 challenging
Calendar 2025 Q4
Should we think about those types of growth rates as sort of achievable in your thoughts for '26
Show response
CEO framed 2026 growth as supply-constrained rather than demand-constrained. Customers making significant capacity investments; growth pacing tied to when incremental capacity comes online rather than demand availability.
I think you talked about high single-digit sequential growth. It does seem quite a bit above your normal seasonality
Show response
CEO attributed above-seasonal Q1 to structural demand shift toward data center and HPC, which more than offsets typical consumer electronics seasonal decline.
Calendar 2025 Q3
Is there a similar dynamic where your customers are adopting new technologies where you can gain content
Show response
CEO highlighted existing CoWoS and HBM technology migrations plus emerging opportunities in hybrid bonding and panel-level packaging over next 12-18 months.
should it revert to sort of more typical EBITDA growth faster than sales over the next quarter or 2
Show response
CEO characterized Q3 margin dynamics as an aberration from currency, mix and investment factors, expecting reversion to Investor Day operating leverage framework.
CTVACorteva3 questions · 3 reporting periods · 0 of 3 challenging
Calendar 2025 Q4
what share of your business will be off patent versus patent and new products in '26
Show response
Robert said portfolio mix stable at about 2/3 differentiated with no major molecules coming off patent unlike broader industry. Expecting Visa fungicide launch in latter part of 2026 targeting Asian soybean rust, which will augment differentiated portfolio.
Calendar 2025 Q3
Could you talk about the remaining 35%? How are these products competitively positioned
Show response
Robert clarified non-differentiated doesn't mean commodity generic, still formulated branded products at lower price points. Strategy is to play in upper tier as an innovation company.
Calendar 2025 Q2
Are you seeing any interest in your products as an alternative to China generics, maybe somewhere else in the world?
Show response
Robert said China generic exports primarily impacting Latin America with some Eastern Europe. Chuck clarified Corteva sells differentiated technology to different customer base, not competing with generics directly.
LYBLyondellBasell2 questions · 2 reporting periods · 0 of 2 challenging
Calendar 2025 Q4
What's your latest thinking in terms of anti-involution policies, what we would have -- any more specific news maybe in the next few quarters there
Show response
Peter noted China PE price increases in January with inventory depletion and ~4% polyolefin growth. Anti-involution discussions intensifying with criteria shifting from 300kt to 500kt cracker minimum. New naphtha consumption tax of $300/tonne for domestic transactions affecting ~11M tonnes of nonintegrated capacity. Global rationalization estimate raised from 21M to 23M+ tonnes, still excluding anti-involution. Decision possible by Q2 but timing uncertain.
Calendar 2025 Q2
Can you just describe the current state of it? How have margins changed sort of in the middle of this more stressful environment
Show response
Peter noted pyrolysis margins remain extremely high above CMDay 2023 levels due to demand exceeding supply. Startup company delays and failures have constrained supply. Positive regulatory momentum in Europe and at U.S. state level. Expects value-based pricing to persist because supply will lag demand for an extended period.
Show 2 more companies
PPGPPG Industries2 questions · 2 reporting periods · 1 of 2 challenging
Calendar 2025 Q4
I was hoping you could just give us some details on total volumes and price for organic growth in '26
Show response
Knavish detailed pricing: positive in Performance and Architectural (39 straight quarters in Europe); flattish Industrial with slight negatives from index carryover and China auto OEM (offset by lower raw materials). Volume growth expected in aerospace, PMC, packaging, modest architectural, auto OEM, and industrial as share gains launch.
Calendar 2025 Q1
In Performance Coatings, your price was up 3%, volumes up [6%] [ph]. So, I would have expected margins to be up a bit more than 20 basis points
Show response
Knavish explained margin headwind from increased growth investments: aerospace debottlenecking for incremental output, PMC capacity additions for 8-quarter volume growth streak, and next-gen digital productivity tools in refinish. These investments are for long-term share capture.
DOWDow Inc.1 question · 1 reporting period · 0 of 1 challenging
Calendar 2024 Q4
I wanted to clarify if your $1 billion cost-reduction target includes the European actions that you will be discussing in the middle of 2025
Show response
Fitterling confirmed European asset actions will be incremental to the $1B cost target with possibly some minor overlap.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| ALB Albemarle Corporation | 7 | 0%none of 7 questions |
| DD DuPont | 5 | 20%1 of 5 questions |
| SHW The Sherwin-Williams Company | 5 | 0%none of 5 questions |
| Q Qnity Electronics, Inc. | 4 | 0%none of 4 questions |
| CTVA Corteva | 3 | 0%none of 3 questions |
| LYB LyondellBasell | 2 | —Rate withheld: fewer than 3 questions |
| PPG PPG Industries | 2 | —Rate withheld: fewer than 3 questions |
| DOW Dow Inc. | 1 | —Rate withheld: fewer than 3 questions |
- ALBAlbemarle Corporation · 7 questions0%none of 7 questions
- DDDuPont · 5 questions20%1 of 5 questions
- SHWThe Sherwin-Williams Company · 5 questions0%none of 5 questions
- QQnity Electronics, Inc. · 4 questions0%none of 4 questions
- CTVACorteva · 3 questions0%none of 3 questions
- LYBLyondellBasell · 2 questions—rate withheld: under 3 questions
- PPGPPG Industries · 2 questions—rate withheld: under 3 questions
- DOWDow Inc. · 1 question—rate withheld: under 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 6 | 0%none of 6 questions | 4 |
| 2025 Q1 | 6 | 33%2 of 6 questions | 4 |
| 2025 Q2 | 5 | 0%none of 5 questions | 4 |
| 2025 Q3 | 5 | 0%none of 5 questions | 4 |
| 2025 Q4 | 7 | 0%none of 7 questions | 6 |
- 2024 Q46 questions · challenge rate 0% (none of 6 questions) · 4 companies
- 2025 Q16 questions · challenge rate 33% (2 of 6 questions) · 4 companies
- 2025 Q25 questions · challenge rate 0% (none of 5 questions) · 4 companies
- 2025 Q35 questions · challenge rate 0% (none of 5 questions) · 4 companies
- 2025 Q47 questions · challenge rate 0% (none of 7 questions) · 6 companies
Topics
Topics tagged on this analyst’s questions.
- Demand8
- Competitive Dynamics6
- Revenue Growth6
- Margin6
- Capex Investment5
- Pricing4
- Cost Pressure4
- Innovation & R&D3
- Supply Chain3
- Cloud & AI2
Show all 17 topics
- Macroeconomic2
- Product Launch1
- Regulation Policy1
- Trade Tariffs1
- Geographic Expansion1
- M&A1
- Capital Allocation1